In addition, databases were queried to investigate the link between ACBD3 expression and survival, relapse and metastatic outcomes for patients divided by receptor status, breast cancer subtype, and response to chemotherapeutic agents. The gene discussed is ACBD3; the disease is breast carcinoma.